2 , 3 GLP-1 receptor agonists delay gastric emptying, decrease food intake, increase insulin secretion in response to meals, and inhibit glucagon release in hyperglycemic and euglycemic states
Facilitating Weight Loss: Semaglutide GLP-1s role in weight loss is multifaceted: Appetite Regulation: By impacting gastric emptying and appetite, it reduces hunger, making it easier for patients to consume fewer calories
Pre-clinical research has reported an increase in VEGF and its receptor VEGFR2, and enhanced migration of endothelial cells
This is especially common during the initial adjustment period
13,46 Intensive glycemic control significantly reduces the incidence and progression of neuropathy in T1DM and T2DM patients
Inflammation Reduction Chronic inflammation is a core driver of many diseases, including autoimmune conditions like thyroid disorders